273 related articles for article (PubMed ID: 32349617)
21. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
[TBL] [Abstract][Full Text] [Related]
22. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
[TBL] [Abstract][Full Text] [Related]
23. Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data.
Zhao C; Wistrand-Yuen P; Lagerbäck P; Tängdén T; Nielsen EI; Friberg LE
Int J Antimicrob Agents; 2020 Jun; 55(6):105941. PubMed ID: 32171741
[TBL] [Abstract][Full Text] [Related]
24. Model-informed dose optimisation of polymyxin-rifampicin combination therapy against multidrug-resistant Acinetobacter baumannii.
Zhao J; Zhu Y; Han ML; Lu J; Yu HH; Wickremasinghe H; Zhou QT; Bergen P; Rao G; Velkov T; Lin YW; Li J
Int J Antimicrob Agents; 2023 Sep; 62(3):106902. PubMed ID: 37380093
[TBL] [Abstract][Full Text] [Related]
25. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
[TBL] [Abstract][Full Text] [Related]
26. Pilot Screening to Determine Antimicrobial Synergies in a Multidrug-Resistant Bacterial Strain Library.
Kim SH; Park C; Chun HS; Lee DG; Choi JK; Lee HJ; Cho SY; Park SH; Choi SM; Choi JH; Yoo JH
Microb Drug Resist; 2016 Jul; 22(5):372-8. PubMed ID: 26974861
[TBL] [Abstract][Full Text] [Related]
27. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria.
Sun W; Weingarten RA; Xu M; Southall N; Dai S; Shinn P; Sanderson PE; Williamson PR; Frank KM; Zheng W
Emerg Microbes Infect; 2016 Nov; 5(11):e116. PubMed ID: 27826141
[TBL] [Abstract][Full Text] [Related]
28. Unveiling synergism of polymyxin B with chloramphenicol derivatives against multidrug-resistant (MDR) Klebsiella pneumoniae.
Idris N; Leong KH; Wong EH; Abdul Rahim N
J Antibiot (Tokyo); 2023 Dec; 76(12):711-719. PubMed ID: 37821539
[TBL] [Abstract][Full Text] [Related]
29. Probing the penetration of antimicrobial polymyxin lipopeptides into gram-negative bacteria.
Deris ZZ; Swarbrick JD; Roberts KD; Azad MA; Akter J; Horne AS; Nation RL; Rogers KL; Thompson PE; Velkov T; Li J
Bioconjug Chem; 2014 Apr; 25(4):750-60. PubMed ID: 24635310
[TBL] [Abstract][Full Text] [Related]
30. Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of
Betts JW; Hornsey M; Higgins PG; Lucassen K; Wille J; Salguero FJ; Seifert H; La Ragione RM
J Med Microbiol; 2019 Oct; 68(10):1552-1559. PubMed ID: 31419210
[No Abstract] [Full Text] [Related]
31. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
[TBL] [Abstract][Full Text] [Related]
32. Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae.
Aye SM; Galani I; Yu H; Wang J; Chen K; Wickremasinghe H; Karaiskos I; Bergen PJ; Zhao J; Velkov T; Giamarellou H; Lin YW; Tsuji BT; Li J
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393492
[TBL] [Abstract][Full Text] [Related]
33. Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.
Abdul Rahim N; Cheah SE; Johnson MD; Yu H; Sidjabat HE; Boyce J; Butler MS; Cooper MA; Fu J; Paterson DL; Nation RL; Bergen PJ; Velkov T; Li J
J Antimicrob Chemother; 2015 Sep; 70(9):2589-97. PubMed ID: 26023209
[TBL] [Abstract][Full Text] [Related]
34. Elimination of Multidrug-Resistant Bacteria by Transition Metal Dichalcogenides Encapsulated by Synthetic Single-Stranded DNA.
Debnath A; Saha S; Li DO; Chu XS; Ulissi ZW; Green AA; Wang QH
ACS Appl Mater Interfaces; 2021 Feb; 13(7):8082-8094. PubMed ID: 33570927
[TBL] [Abstract][Full Text] [Related]
35. Polymyxin B in Combination with Glycerol Monolaurate Exerts Synergistic Killing against Gram-Negative Pathogens.
Zheng Y; Yang N; Ding Y; Li J; Liu Y; Chen H; Li J
Pathogens; 2022 Aug; 11(8):. PubMed ID: 36014995
[TBL] [Abstract][Full Text] [Related]
36. A novel decoy strategy for polymyxin resistance in
Park J; Kim M; Shin B; Kang M; Yang J; Lee TK; Park W
Elife; 2021 Jun; 10():. PubMed ID: 34180396
[TBL] [Abstract][Full Text] [Related]
37. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
38. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli.
Abichabki N; Zacharias LV; Moreira NC; Bellissimo-Rodrigues F; Moreira FL; Benzi JRL; Ogasawara TMC; Ferreira JC; Ribeiro CM; Pavan FR; Pereira LRL; Brancini GTP; Braga GÚL; Zuardi AW; Hallak JEC; Crippa JAS; Lanchote VL; Cantón R; Darini ALC; Andrade LN
Sci Rep; 2022 Apr; 12(1):6454. PubMed ID: 35440801
[TBL] [Abstract][Full Text] [Related]
39. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.
Tyrrell JM; Aboklaish AF; Walsh TR; Vaara T; Vaara M
Peptides; 2019 Feb; 112():149-153. PubMed ID: 30586602
[TBL] [Abstract][Full Text] [Related]
40. In vitro analysis of synergistic combination of polymyxin B with 12 other antibiotics against MDR Acinetobacter baumannii isolated from a Chinese tertiary hospital.
Liu H; Hu D; Wang D; Wu H; Pan Y; Chen X; Qi L; Li L; Liang R
J Antibiot (Tokyo); 2023 Jan; 76(1):20-26. PubMed ID: 36307731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
